• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Philip Morris International Reports 2023 Fourth-Quarter and Full-Year Results; Delivers 2023 Full-Year Reported Diluted EPS of $5.02 and Adjusted Diluted EPS of $6.01, Representing Currency-Neutral Growth of 11.0%; Provides 2024 EPS Forecast

    2/8/24 6:59:00 AM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $PM alert in real time by email

    Regulatory News:

    Philip Morris International Inc. (PMI) (NYSE:PM) today announces its 2023 fourth-quarter and full-year results. Further explanation of PMI's use of non-GAAP measures cited in this document and reconciliations to the most directly comparable U.S. GAAP measures can be found in the "Non-GAAP Measures, Glossary and Explanatory Notes" section of this release, in Exhibit 99.2 to the company's Form 8-K dated February 8, 2024, and at www.pmi.com/2023Q4earnings.

    2023 FOURTH-QUARTER AND FULL-YEAR HIGHLIGHTS

     

     

    Fourth-Quarter

     

    Full-Year

     

     

     

     

    Change vs. Q4 2022

     

     

    Change vs. FY 2022

     

     

    Amount

     

    Reported

     

    Adjusted

     

    Amount

    Reported

     

    Adjusted

    Total Cig. & HTU Shipment Volume (units bn)

     

    185.1

     

    (0.5)%

     

     

     

     

    738.2

    1.0%

     

     

     

    HTU Shipment Volume (units bn)

     

    34.0

     

    6.1%

     

     

     

     

    125.3

    14.7%

     

     

     

    Oral Product Shipment Volume (mn cans) (1)

     

    219.6

     

    +100%

     

    23.4%

    (2)

     

    799.3

    +100%

     

    16.8%

    (2)

    Net Revenues ($ bn)

     

    $9.0

     

    11.0%

     

    8.3%

    (3)

     

    $35.2

    10.7%

     

    7.8%

    (3)

    Smoke-Free Product Net Revenues ($ bn)

     

    $3.6

     

    21.1%

     

    13.6%

    (3)

     

    $12.8

    26.0%

     

    12.8%

    (3)

    - % of Total Net Revenues

     

    39.3%

     

    3.3pp

     

     

     

     

    36.5%

    4.4pp

     

     

     

    Operating Income ($ bn)

     

    $2.9

     

    (1.2)%

     

    8.0%

    (3)

     

    $11.6

    (5.6)%

     

    3.7%

    (3)

    Diluted Earnings per Share

     

    $1.41

     

    (8.4)%

     

     

     

     

    $5.02

    (13.6)%

     

     

     

    Adjusted Diluted Earnings per Share

     

    $1.36

     

     

     

    12.2%

    (4)

     

    $6.01

     

     

    11.0%

    (4)

    (1) Excludes snuff, snuff leaf and U.S. chew

    (2) On a pro forma basis (including Swedish Match in all periods)

    (3) On an organic basis

    (4) Excluding currency

    Fourth-Quarter

    • Smoke-free products accounted for 39.3% of total net revenues
    • Adjusted in-market sales volume for HTUs, which excludes the net unfavorable impact of estimated distributor and wholesaler inventory movements, up by an estimated 13.9%
    • Total IQOS users at quarter-end up by 1.2 million versus September 2023
    • Market share for HTUs in IQOS markets up by 1.3 points to 9.7%
    • ZYN nicotine pouch shipment volume in the U.S. of 116.3 million cans, representing growth of 78.2% versus fourth-quarter 2022 Swedish Match shipments of 65.3 million cans
    • Combustible tobacco net revenue growth of 5.3% on both a reported and organic basis, driven by pricing of 9.9%

    Full-Year

    • Third consecutive year of volume growth driven by HTUs
    • Adjusted in-market sales volume for HTUs, which excludes the net unfavorable impact of estimated distributor and wholesaler inventory movements, up by an estimated 14.8%
    • Total IQOS users at year-end estimated at approximately 28.6 million (up by 3.7 million versus December 2022), of which approximately 20.8 million had switched to IQOS and stopped smoking
    • Market share for HTUs in IQOS markets up by 1.2 points to 9.1%
    • ZYN nicotine pouch shipment volume in the U.S. of 384.8 million cans, representing growth of 62.0% versus 2022 Swedish Match shipments of 237.5 million cans
    • Increased regular quarterly dividend in September by 2.4% to $1.30 per share, or an annualized rate of $5.20 per share
    • Combustible tobacco net revenue growth of 3.5%; growth of 5.5% on an organic basis, driven by pricing of 8.9%
    • Organic growth in adjusted operating income driven by the performance of smoke-free products

    "Our business delivered a strong finish to 2023 and we achieved a number of remarkable milestones on our path to becoming a smoke-free company," said Jacek Olczak, Chief Executive Officer.

    "We are pleased that smoke-free products reached nearly 40% of our total net revenues and over 40% of our gross profit in the fourth quarter. This was led by the continued growth of IQOS, which has now surpassed Marlboro in terms of net revenues, confirming its position as the leading premium nicotine brand less than 10 years from launch. The fourth quarter also marked the first anniversary of our combination with Swedish Match, which delivered very strong results in 2023 driven by the stellar U.S. performance of ZYN."

    "We are entering 2024 with strong momentum, and we expect it will be another year of excellent performance underpinned by an acceleration in organic smoke-free net revenue and profit growth."

    2023 FULL-YEAR SUMMARY

    Adjusted net revenues increased by 7.8% on an organic basis, driven by total cigarette and HTU shipment volume growth of 1.0% (reflecting growth of 14.7% for HTUs and a decline of 1.4% for cigarettes), favorable category mix of smoke-free products and positive pricing.

    Adjusted operating income increased by 3.7% on an organic basis with a substantial acceleration in the second half of the year, as supply chain disruptions and ILUMA-related factors continued to dissipate, coupled with an accelerating contribution from smoke-free products.

    Adjusted diluted EPS of $6.01 increased by 11.0%, excluding currency, driven primarily by the organic growth in adjusted operating income, as well as the results of the Swedish Match business and its strong performance led by ZYN in the U.S. The $0.20 unfavorable currency variance in the fourth quarter includes a $0.09 balance-sheet-related currency impact in Argentina. While the company's affiliate in Argentina remains subject to highly inflationary accounting treatment, with the U.S. dollar treated as the functional currency, the impact reflects the depreciation of Argentine peso-denominated monetary net assets, which impacts earnings on a periodic basis when translated to U.S. dollars and are also subject to capital controls.

     

     

    Full-Year

     

     

    2023

     

    2022

     

    Currency

     

    Var. excl.

    Currency

    Reported Diluted EPS

     

    $

    5.02

     

    $

    5.81

     

    $

    (0.63

    )

    (2.8

    )%

    Asset impairment and exit costs

     

     

    0.06

     

     

    —

     

     

     

    Termination of distribution arrangement in the Middle East

     

     

    0.04

     

     

    —

     

     

     

    Income tax impact associated with Swedish Match AB financing

     

     

    (0.11

    )

     

    (0.13

    )

     

     

    Swedish Match AB acquisition accounting related item

     

     

    0.01

     

     

    0.06

     

     

     

    Impairment of goodwill and other intangibles

     

     

    0.44

     

     

    0.06

     

     

     

    Amortization of intangibles

     

     

    0.25

     

     

    0.09

     

     

     

    Charges related to the war in Ukraine

     

     

    0.03

     

     

    0.08

     

     

     

    Costs associated with Swedish Match AB offer

     

     

    —

     

     

    0.06

     

     

     

    South Korea indirect tax charge

     

     

    0.11

     

     

    —

     

     

     

    Termination of agreement with Foundation for a Smoke-Free World

     

     

    0.07

     

     

    —

     

     

     

    Fair value adjustment for equity security investments

     

     

    (0.02

    )

     

    (0.02

    )

     

     

    Tax items (1)

     

     

    0.11

     

     

    (0.03

    )

     

     

    Adjusted Diluted EPS

     

    $

    6.01

     

    $

    5.98

     

    $

    (0.63

    )

    11.0

    %

    (1) 2023 Tax items relate to the unilateral suspension of certain Russian double tax treaties by the Russian government

    2024 FULL-YEAR FORECAST

     

    Full-Year

     

    2024

    Forecast

     

    2023

     

    Growth

     

     

     

     

     

     

     

     

     

    Reported Diluted EPS

    $5.90

    -

    $6.02

     

    $ 5.02

     

     

     

     

    Adjustments:

     

     

     

     

     

     

     

     

     

    Asset impairment and exit costs

    —

     

    0.06

     

     

     

     

    Termination of distribution arrangement in the Middle East

    —

     

    0.04

     

     

     

     

    Income tax impact associated with Swedish Match AB financing

    —

     

    (0.11)

     

     

     

     

    Amortization of intangibles

    0.42

     

    0.25

     

     

     

     

    Impairment of goodwill and other intangibles

    —

     

    0.44

     

     

     

     

    Charges related to the war in Ukraine

    —

     

    0.03

     

     

     

     

    Swedish Match AB acquisition accounting related item

    —

     

    0.01

     

     

     

     

    Termination of agreement with Foundation for a Smoke-Free World

    —

     

    0.07

     

     

     

     

    South Korea indirect tax charge

    —

     

    0.11

     

     

     

     

    Fair value adj. for equity security investments

    —

     

    (0.02)

     

     

     

     

    Tax items (1)

    —

     

    0.11

     

     

     

     

    Total Adjustments

    0.42

     

    0.99

     

     

     

     

    Adjusted Diluted EPS

    $6.32

    -

    $6.44

     

    $ 6.01

     

     

     

     

    Less: Currency

    (0.11)

     

     

     

     

     

     

    Adjusted Diluted EPS, excluding currency

    $6.43

    -

    $6.55

     

    $ 6.01

     

    7.0%

    -

    9.0%

    (1) 2023 Tax items relate to the unilateral suspension of certain Russian double tax treaties by the Russian government

    Reported diluted EPS is forecast to be in a range of $5.90 to $6.02, at prevailing exchange rates, versus reported diluted EPS of $5.02 in 2023. Excluding a total 2024 adjustment of $0.42 per share and an adverse currency impact of $0.11, at prevailing exchange rates, this forecast represents a projected increase of 7.0% to 9.0% versus adjusted diluted EPS of $6.01 in 2023, as outlined in the above table.

    2024 Full-Year Forecast Assumptions

    This forecast assumes:

    • An estimated total international industry volume decline for cigarettes and HTUs, excluding China and the U.S., of -2% to flat;
    • Total cigarette, HTU and oral smoke-free product shipment volume growth for PMI of flat to +1% driven by smoke-free products;
    • 14% to 16% adjusted in-market sales volume growth for HTUs, including an approximate 2 billion units adverse impact from consumer adjustment to the EU characterizing flavor ban, and essentially no growth in Russia, resulting in HTU shipment volumes of more than 140 billion units;
    • Nicotine pouch shipment volume in the U.S. of approximately 520 million cans;
    • Net revenue growth of 6.5% to 8% on an organic basis;
    • Organic operating income growth of 8% to 9.5%;
    • An acceleration in organic smoke-free net revenue and gross profit growth compared to 2023;
    • Broadly unchanged net revenue and adjusted operating loss in Wellness and Healthcare segment;
    • No earnings impact from any potential favorable court ruling related to the legality of a supplemental tax surcharge on HTUs in Germany, which went into effect in 2022 (see PMI's first-quarter 2023 press release from April 20, 2023, for additional detail). The company currently expects to have greater visibility on the outcome in the first quarter of 2024;
    • Full-year amortization of acquired intangibles of $0.42 per share, which includes an estimate of amortization of IQOS commercialization rights in the U.S. following the closing of the agreement to end our commercial relationship with Altria Group, Inc. covering IQOS in the U.S. effective May 1, 2024. We currently estimate that the incremental increase in amortization expense in 2024, as a result of this transaction, will be approximately $370 million on a pre-tax basis for the remaining 8 months of the year. For full year 2025 through 2028, we currently estimate an annual impact of approximately $555 million on a pre-tax basis;
    • Net financing costs of approximately $1.3 to $1.4 billion;
    • An effective tax rate, excluding discrete tax events, of approximately 21% to 22%;
    • Operating cash flow of $10 to $11 billion at prevailing exchange rates, subject to year-end working capital requirements;
    • Capital expenditures of approximately $1.2 billion, partly reflecting investments in ZYN capacity in the U.S.;
    • Net debt to adjusted EBITDA ratio improvement of 0.3x to 0.5x at prevailing exchange rates as we continue to target a ratio of around 2x by the end of 2026;
    • No share repurchases in 2024; and
    • A strong start to 2024 with first quarter adjusted diluted EPS of $1.37 to $1.42, including an estimated adverse currency impact of 10 cents at prevailing exchange rates.

    Factors described in the Forward-Looking and Cautionary Statements section of this release represent continuing risks to these projections.

    New Segment Structure

    Following the combination and the progress in 2023 toward integration of the Swedish Match business into the existing PMI regional segment structure, PMI will update its segment reporting by including Swedish Match results in the four existing geographical regions. As of the first quarter of 2024, PMI will report on this basis. The company plans to disclose select historical financial information for the 2021 to 2023 period reflecting the above mentioned change in the coming weeks.

    Global Patent Settlement

    On February 2, 2024 PMI announced that it has reached a global settlement with British American Tobacco p.l.c. that resolves all ongoing patent infringement litigation between the parties related to heated tobacco and vapor products. Please see the Form 8-K dated February 2, 2024 for additional detail.

    Conference Call

    A conference call hosted by Jacek Olczak, Chief Executive Officer, and Emmanuel Babeau, Chief Financial Officer, will be webcast at 9:00 a.m., Eastern Time, on February 8, 2024. Access the call at www.pmi.com/2023Q4earnings.

    TOTAL MARKET, CONSOLIDATED SHIPMENT VOLUME & MARKET SHARE

    Total Market Volume

    Full-Year

    Estimated international industry volume (excluding China and the U.S.) for cigarettes and HTUs of 2.6 trillion, decreased by 1.6%, reflecting declines in the SSEA, CIS & MEA Region, the Europe Region and the Americas Region, partly offset by an increase in the EA, AU & PMI DF Region, as described in the Regional sections.

    Consolidated Shipment Volume

    PMI Cigarettes and HTUs

    Fourth-Quarter

    Full-Year

    (million units)

    2023

    2022

    Change

    2023

    2022

    Change

    Cigarettes

    151,094

    154,026

    (1.9)%

    612,949

    621,908

    (1.4)%

    Heated Tobacco Units

    33,972

    32,021

    6.1%

    125,263

    109,169

    14.7%

    Total Cigarettes and HTUs

    185,066

    186,047

    (0.5)%

    738,212

    731,077

    1.0%

    PMI Oral Products (1)

    Fourth-Quarter

    Full-Year

    (million cans)

    2023

    2022

    Change

    2023

    2022

    Change

    Nicotine Pouches

    125.7

    39.8

    +100%

    421.1

    42.5

    +100%

    Snus

    61.8

    42.8

    44.4%

    240.4

    54.8

    +100%

    Moist Snuff

    31.2

    16.0

    95.5%

    133.7

    16.0

    +100%

    Other

    0.8

    —

    —%

    4.2

    —

    —%

    Total Oral Products

    219.6

    98.6

    +100%

    799.3

    113.2

    +100%

    (1) Excluding snuff, snuff leaf and U.S. chew

    Note: Sum may not foot due to roundings.

    Fourth-Quarter

    PMI's total cigarette and HTU shipment volume decreased by 0.5%, reflecting an 6.1% increase in HTU shipments across all regions except EA, AU & PMI DF Region, partly offset by a 1.9% decline in cigarette shipments with declines in the EA, AU & PMI DF Region, the Americas Region, as well as the SSEA, CIS & MEA Region, and broadly stable cigarette shipments in the Europe Region. Cigarette shipment volume for Marlboro decreased by 0.8% to 60.2 billion units, due primarily to the Philippines.

    PMI's total oral product shipment volume increased by over 100%, driven by the Swedish Match acquisition. On a pro forma basis (including Swedish Match in all periods), it increased by 23.4%, primarily reflecting growth in nicotine pouches (particularly in the U.S.), partly offset by a decline for snus (mainly in Scandinavia). Swedish Match's total oral product shipment volume increased by 21.9% versus its corresponding shipments in 2022.

    Adjusted in-market sales for HTUs increased by 13.9%, including growth in Europe of 13.1%, Japan of 13.4%. Excluding Russia and Ukraine, adjusted in-market sales for HTUs increased by 15.0%. The net unfavorable impact of estimated distributor inventory movements for HTUs was driven primarily by Japan.

    Full-Year

    PMI's total cigarette and HTU shipment volume increased by 1.0%, reflecting an 14.7% increase in HTU shipments across all regions, partly offset by a 1.4% decline in cigarette shipments due to declines in the Europe, EA, AU & PMI DF, and Americas Regions, partly offset by the SSEA, CIS & MEA Region. Cigarette shipment volume for Marlboro decreased by 1.9% to 240.0 billion units, due primarily to the Philippines.

    PMI's total oral product shipment volume increased by over 100%, driven by the Swedish Match acquisition. On a pro forma basis (including Swedish Match in all periods), it increased by 16.8%, primarily reflecting the same factors as in the quarter. Swedish Match's total oral product shipment volume increased by 17.1% versus its corresponding shipments in 2022.

    Adjusted in-market sales for HTUs increased by 14.8% (in line with full-year HTUs shipment volume growth of 14.7%), including growth in Europe of 17.6% and Japan of 14.5%. Excluding Russia and Ukraine, adjusted in market sales for HTUs increased by 17.1%.

    International Share of Market - Cigarettes and HTUs

     

    Fourth-Quarter

    Full Year

    2023

    2022

    Change

    (pp)

    2023

    2022

    Change

    (pp)

     

     

     

     

     

     

     

    Total International Market Share (1)

    28.6%

    28.1%

    0.5

    28.3%

    27.7%

    0.6

    Cigarettes

    23.7%

    23.7%

    —

    23.7%

    23.6%

    0.1

    HTU

    4.9%

    4.3%

    0.6

    4.7%

    4.1%

    0.6

    Cigarette over Cigarette Market Share (2)

    25.3%

    25.2%

    0.1

    25.2%

    25.0%

    0.2

    (1) Defined as PMI's cigarette and heated tobacco unit in-market sales volume as a percentage of total industry cigarette and heated tobacco unit sales volume, excluding China and the U.S., including cigarillos in Japan

    (2) Defined as PMI's cigarette in-market sales volume as a percentage of total industry cigarette sales volume, excluding China and the U.S., including cigarillos in Japan

    Note: Sum of share of market by product categories might not foot to total due to roundings.

    CONSOLIDATED FINANCIAL SUMMARY

    Fourth-Quarter

    Financial Summary - Quarters Ended December 31,

     

     

     

     

     

    Change

    Fav./(Unfav.)

     

    Variance

    Fav./(Unfav.)

     

    2023

     

    2022

     

    Total

     

    Excl.

    Curr. &

    Acquis.

     

    Total

     

    Cur-

    rency

     

    Acqui-

    sitions

     

    Price

     

    Vol/

    Mix

     

    Cost/

    Other

    (in millions)

     

     

     

     

     

     

     

     

     

     

    Net Revenues

     

    $

    9,047

     

    $

    8,152

     

     

    11.0

    %

    8.3

    %

     

    895

     

    (78

    )

    299

     

    631

    50

     

    (7

    )

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Cost of Sales (1)

     

     

    (3,462

    )

     

    (3,211

    )

     

    (7.8

    )%

    (3.8

    )%

     

    (251

    )

    (39

    )

    (90

    )

    —

    (103

    )

    (19

    )

    Marketing, Administration and Research Costs (2)

     

     

    (2,696

    )

     

    (2,017

    )

     

    (33.7

    )%

    (19.0

    )%

     

    (679

    )

    (184

    )

    (112

    )

    —

    —

     

    (383

    )

    Operating Income

     

    $

    2,889

     

    $

    2,924

     

     

    (1.2

    )%

    5.8

    %

     

    (35

    )

    (301

    )

    97

     

    631

    (53

    )

    (409

    )

    Amortization of Intangibles

     

     

    (129

    )

     

    (58

    )

     

    -(100

    )%

    (51.7

    )%

     

    (71

    )

    —

     

    (41

    )

    —

    —

     

    (30

    )

    Charges related to the war in Ukraine

     

     

    (34

    )

     

    (23

    )

     

    (47.8

    )%

    (47.8

    )%

     

    (11

    )

    —

     

    —

     

    —

    —

     

    (11

    )

    Costs associated with Swedish Match AB offer

     

     

    —

     

     

    154

     

     

    -(100

    )%

    -(100

    )%

     

    (154

    )

    —

     

    —

     

    —

    —

     

    (154

    )

    Swedish Match AB acquisition accounting related items

     

     

    —

     

     

    (125

    )

     

    +100

    %

    +100

    %

     

    125

     

    —

     

    —

     

    —

    —

     

    125

     

    Adjusted Operating Income

     

    $

    3,052

     

    $

    2,976

     

     

    2.6

    %

    8.0

    %

     

    76

     

    (301

    )

    138

     

    631

    (53

    )

    (339

    )

    Adjusted Operating Income Margin

     

     

    33.7

    %

     

    36.5

    %

     

    (2.8

    )pp

    (0.1

    )pp

     

     

     

     

     

     

     

    (1) Includes $18 million in 2023 and $157 million in 2022 related to the special items below.

    (2) Includes $145 million in 2023 and $(105) million in 2022 related to the special items below.

    Net revenues increased by 8.3% on an organic basis, mainly reflecting: a favorable pricing variance, primarily driven by higher combustible tobacco pricing; and favorable volume/mix, mainly driven by higher HTU volume, partially offset by lower cigarette volume.

    Adjusted operating income increased by 8.0% on an organic basis, mainly reflecting: the favorable pricing variance; partially offset by higher marketing, administration and research costs (primarily due to inflationary impacts, notably related to wages) as well as higher manufacturing costs. Slightly unfavorable volume/mix, mainly driven by lower cigarette volume, was partly offset by higher HTU volume.

    Full-Year

    Financial Summary - Years Ended December 31,

     

     

     

     

     

    Change

    Fav./(Unfav.)

     

    Variance

    Fav./(Unfav.)

     

    2023

     

    2022

     

    Total

     

    Excl.

    Curr. &

    Acquis

     

    Total

     

    Cur-

    rency

     

    Acqui-

    sitions

     

    Price

     

    Vol/

    Mix

     

    Cost/

    Other

    (in millions)

     

     

     

     

     

     

     

     

     

     

    Net Revenues

     

    $

    35,174

     

    $

    31,762

     

     

    10.7

    %

    7.6

    %

     

    3,412

     

    (1,112

    )

    2,113

     

    1,940

    664

     

    (193

    )

    Termination of distribution arrangement in the Middle East

     

     

    (80

    )

     

    —

     

     

    —

    %

    —

    %

     

    (80

    )

    —

     

    —

     

    —

    —

     

    (80

    )

    Adjusted Net Revenues

     

    $

    35,254

     

    $

    31,762

     

     

    11.0

    %

    7.8

    %

     

    3,492

     

    (1,112

    )

    2,113

     

    1,940

    664

     

    (113

    )

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Net Revenues

     

    $

    35,174

     

    $

    31,762

     

     

    10.7

    %

    7.6

    %

     

    3,412

     

    (1,112

    )

    2,113

     

    1,940

    664

     

    (193

    )

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Cost of Sales (1)

     

     

    (12,893

    )

     

    (11,402

    )

     

    (13.1

    )%

    (8.4

    )%

     

    (1,491

    )

    167

     

    (695

    )

    —

    (755

    )

    (208

    )

    Marketing, Administration and Research Costs (2)

     

     

    (10,060

    )

     

    (8,114

    )

     

    (24.0

    )%

    (13.5

    )%

     

    (1,946

    )

    (128

    )

    (724

    )

    —

    —

     

    (1,094

    )

    Impairment of Goodwill

     

     

    (665

    )

     

    —

     

     

    —

    %

    —

    %

     

    (665

    )

    —

     

    —

     

    —

    —

     

    (665

    )

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Operating Income

     

    $

    11,556

     

    $

    12,246

     

     

    (5.6

    )%

    (2.5

    )%

     

    (690

    )

    (1,073

    )

    694

     

    1,940

    (91

    )

    (2,160

    )

    Asset Impairment & Exit Costs

     

     

    (109

    )

     

    —

     

     

    —

    %

    —

    %

     

    (109

    )

    —

     

    —

     

    —

    —

     

    (109

    )

    Termination of distribution arrangement in the Middle East (3)

     

     

    (80

    )

     

    —

     

     

    —

    %

    —

    %

     

    (80

    )

    —

     

    —

     

    —

    —

     

    (80

    )

    Impairment of Goodwill and Other Intangibles (4)

     

     

    (680

    )

     

    (112

    )

     

    -(100

    )%

    -(100

    )%

     

    (568

    )

    —

     

    —

     

    —

    —

     

    (568

    )

    Amortization of Intangibles

     

     

    (497

    )

     

    (159

    )

     

    -(100

    )%

    (14.5

    )%

     

    (338

    )

    —

     

    (315

    )

    —

    —

     

    (23

    )

    Charges related to the war in Ukraine

     

     

    (53

    )

     

    (151

    )

     

    64.9

    %

    64.9

    %

     

    98

     

    —

     

    —

     

    —

    —

     

    98

     

    Costs associated with Swedish Match AB offer

     

     

    —

     

     

    (115

    )

     

    +100

    %

    +100

    %

     

    115

     

    —

     

    —

     

    —

    —

     

    115

     

    Swedish Match AB acquisition accounting related items

     

     

    (18

    )

     

    (125

    )

     

    85.6

    %

    +100

    %

     

    107

     

    —

     

    (18

    )

    —

    —

     

    125

     

    South Korea Indirect Tax Charge

     

     

    (204

    )

     

    —

     

     

    —

    %

    —

    %

     

    (204

    )

    —

     

    —

     

    —

    —

     

    (204

    )

    Termination of agreement with Foundation for a Smoke-Free World

     

     

    (140

    )

     

    —

     

     

    —

    %

    —

    %

     

    (140

    )

    —

     

    —

     

    —

    —

     

    (140

    )

    Adjusted Operating Income

     

    $

    13,337

     

    $

    12,908

     

     

    3.3

    %

    3.7

    %

     

    429

     

    (1,073

    )

    1,027

     

    1,940

    (91

    )

    (1,374

    )

    Adjusted Operating Income Margin

     

     

    37.8

    %

     

    40.6

    %

     

    (2.8

    )pp

    (1.5

    )pp

     

     

     

     

     

     

     

    (1) Includes $90 million in 2023 and $356 million in 2022 related to the special items below.

    (2) Includes $946 million in 2023 and $306 million in 2022 related to the special items below.

    (3) Included in Net Revenues above.

    (4) Includes $665 million impairment of goodwill.

    Adjusted net revenues increased by 7.8% on an organic basis, mainly reflecting: a favorable pricing variance, primarily driven by higher combustible tobacco pricing, and favorable volume/mix, mainly driven by higher HTU volume, partially offset by lower cigarette volume and lower fees for certain distribution rights billed to customers in certain markets.

    Cost of sales, excluding currency and acquisitions, increased by 8.4%, driven by higher manufacturing costs (primarily due to inflationary impacts, notably related to direct materials, tobacco leaf and energy, partly offset by productivity) and unfavorable volume/mix, mainly reflecting unfavorable category mix (notably due to lower cigarette volume and higher HTU volume), as well as the technical impact of third-party manufacturing in Indonesia. This increase was partially offset by the Swedish Match AB acquisition accounting related item in 2022, the impairment charge of other intangible assets in 2022 and lower charges related to the War in Ukraine.

    Adjusted operating income increased by 3.7% on an organic basis, mainly reflecting: the favorable pricing variance; partly offset by higher marketing, administration and research costs (primarily due to inflationary impacts, notably related to wages, and lower commercial investments in the prior year period); higher manufacturing costs (as explained for cost of sales); and the impact of lower fees for certain distribution rights, as noted for net revenues.

    EUROPE REGION

    Total Market, PMI Shipment & Market Share Commentaries

    Europe Key Data

    Fourth-Quarter

    Full-Year

     

     

     

    Change

     

     

    Change

     

    2023

     

    2022

     

    % / pp

    2023

     

    2022

     

    % / pp

    PMI Shipment Volume (million units)

     

     

     

     

     

     

    Cigarettes

    39,330

     

    39,339

     

    —

    %

    165,593

     

    170,658

     

    (3.0

    )%

    Heated Tobacco Units

    14,310

     

    12,921

     

    10.7

    %

    49,269

     

    45,417

     

    8.5

    %

    Total Europe

    53,640

     

    52,260

     

    2.6

    %

    214,862

     

    216,075

     

    (0.6

    )%

     

     

     

     

     

     

     

    PMI Market Share

     

     

     

     

     

     

    Cigarettes

    30.3

    %

    30.6

    %

    (0.3

    )

    30.3

    %

    31.1

    %

    (0.8

    )

    Heated Tobacco Units

    10.0

    %

    8.9

    %

    1.1

     

    9.1

    %

    7.8

    %

    1.3

     

    Total Europe

    40.3

    %

    39.5

    %

    0.8

     

    39.4

    %

    39.0

    %

    0.4

     

    Note: Sum may not foot due to roundings.

    Fourth-Quarter

    The estimated total market for cigarettes and HTUs in the Region decreased by 0.9% to 130.8 billion units, reflecting a 2.6% decline for cigarettes, partly offset by a 13.2% increase for HTUs. The decrease in the estimated total market was predominantly due to the UK (down by 16.7%), the Czech Republic (down by 14.7%) and France (down by 7.3%), partly offset by Italy (up by 2.5%).

    PMI's total cigarette and HTU shipment volume in the Region increased by 2.6% to 53.6 billion units, mainly due to Poland (up by 10.6%), Italy (up by 4.0%) and Ukraine (up by 14.9%), partly offset by France (down by 13.7%; or by 8.3% excluding the net unfavorable impact of estimated distributor inventory movements) and Germany (down by 6.2%).

    PMI's estimated HTU adjusted in-market sales volume in the Region increased by 13.1% in the quarter, reflecting the strong continued growth momentum for IQOS (including in Germany, where adjusted in-market sales volume for HTUs increased by 19.5%).

    PMI's HTU share of the total cigarette and HTU market in the Region increased by 1.1 points, or by 1.2 points on an adjusted basis.

    Full-Year

    The estimated total market for cigarettes and HTUs in the Region decreased by 1.3% to 542.3 billion units, reflecting a 3.0% decline for cigarettes, partly offset by a 15.6% increase for HTUs. The decrease in the estimated total market was predominantly due to the UK (down by 15.4%), France (down by 8.2%), Germany (down by 1.8%) and Spain (down by 2.4%), partly offset by Poland (up by 1.8%).

    PMI's total cigarette and HTU shipment volume in the Region decreased by 0.6% to 214.9 billion units, mainly due to Germany (down by 6.0%), Italy (down by 2.8%; or up by 0.4% excluding the net unfavorable impact of estimated distributor inventory movements) and France (down by 7.3%), partly offset by Poland (up by 9.4%).

    PMI's estimated HTU adjusted in-market sales volume in the Region increased by 17.6%, including growth in Germany and Italy of 29.7% and 16.6%, respectively.

    PMI's HTU share of the total cigarette and HTU market in the Region increased by 1.3 points, or by 1.5 points on an adjusted basis.

    Financial Summary

    Fourth-Quarter

    Financial Summary - Quarters Ended December 31,

     

     

     

     

     

    Change

    Fav./(Unfav.)

     

    Variance

    Fav./(Unfav.)

     

    2023

     

    2022

     

    Total

     

    Excl.

    Curr. &

    Acquis.

     

    Total

     

    Cur-

    rency

     

    Acqui-

    sitions

     

    Price

     

    Vol/

    Mix

     

    Cost/

    Other

    (in millions)

     

     

     

     

     

     

     

     

     

     

    Net Revenues

     

    $

    3,614

     

    $

    3,064

     

     

    18.0

    %

    9.6

    %

     

    550

     

    255

    —

    187

    108

    —

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Operating Income

     

    $

    1,566

     

    $

    1,355

     

     

    15.6

    %

    6.6

    %

     

    211

     

    122

    —

    187

    146

    (244

    )

    Adjustments (1)

     

     

    (44

    )

     

    38

     

     

    -(100

    )%

    -(100

    )%

     

    (82

    )

    —

    —

    —

    —

    (82

    )

    Adjusted Operating Income

     

    $

    1,610

     

    $

    1,317

     

     

    22.2

    %

    13.0

    %

     

    293

     

    122

    —

    187

    146

    (162

    )

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Adjusted Operating Income Margin

     

     

    44.5

    %

     

    43.0

    %

     

    1.5

    pp

    1.3

    pp

     

     

     

     

     

     

     

    (1) See Schedule 8 in Exhibit 99.2 to the Form 8-K dated February 8, 2024, for additional detail.

    Net revenues increased by 9.6% on an organic basis, reflecting: a favorable pricing variance, mainly driven by higher combustible tobacco pricing; and favorable volume/mix, primarily driven by higher HTU volume and favorable mix, partly offset by lower cigarette volume, as well as unfavorable cigarette mix.

    Adjusted operating income increased by 13.0% on an organic basis, primarily reflecting: the favorable pricing variance; favorable volume/mix, mainly reflecting higher HTU volume, partly offset by lower cigarette volume, as well as unfavorable cigarette mix; partly offset by higher marketing, administration and research costs (primarily due to inflationary impacts) as well as higher manufacturing costs.

    Full-Year

    Financial Summary - Years Ended December 31,

     

     

     

     

     

    Change

    Fav./(Unfav.)

     

    Variance

    Fav./(Unfav.)

     

    2023

     

    2022

     

    Total

     

    Excl.

    Curr. &

    Acquis.

     

    Total

     

    Cur-

    rency

     

    Acqui-

    sitions

     

    Price

     

    Vol/

    Mix

     

    Cost/

    Other

    (in millions)

     

     

     

     

     

     

     

     

     

     

    Net Revenues

     

    $

    13,598

     

    $

    12,869

     

     

    5.7

    %

    3.7

    %

     

    729

    249

    —

    540

    (60

    )

    —

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Operating Income

     

    $

    6,012

     

    $

    5,802

     

     

    3.6

    %

    0.4

    %

     

    210

    186

    —

    540

    (79

    )

    (437

    )

    Adjustments (1)

     

     

    (202

    )

     

    (242

    )

     

    16.5

    %

    16.5

    %

     

    40

    —

    —

    —

    —

     

    40

     

    Adjusted Operating Income

     

    $

    6,214

     

    $

    6,044

     

     

    2.8

    %

    (0.3

    )%

     

    170

    186

    —

    540

    (79

    )

    (477

    )

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Adjusted Operating Income Margin

     

     

    45.7

    %

     

    47.0

    %

     

    (1.3

    )pp

    (1.8

    )pp

     

     

     

     

     

     

     

    (1) See Schedule 9 in Exhibit 99.2 to the Form 8-K dated February 8, 2024, for additional detail.

    Net revenues increased by 3.7% on an organic basis, reflecting: a favorable pricing variance, mainly driven by higher combustible tobacco pricing; partially offset by unfavorable volume/mix, mainly due to lower cigarette volume, as well as unfavorable cigarette mix, partly offset by higher HTU volume.

    Adjusted operating income decreased by 0.3% on an organic basis, primarily reflecting: higher marketing, administration and research costs (mainly due to inflationary impacts and lower commercial investments in the prior year period); higher manufacturing costs (primarily due to inflationary impacts); and unfavorable volume/mix, mainly due to the same factors as for net revenues; partly offset by the favorable pricing variance.

    SSEA, CIS & MEA REGION

    Total Market, PMI Shipment & Market Share Commentaries

    PMI Shipment Volume

    Fourth-Quarter

     

    Full-Year

    (million units)

    2023

    2022

    Change

     

    2023

    2022

    Change

    Cigarettes

    83,009

    83,920

    (1.1)%

     

    333,353

    331,026

    0.7%

    Heated Tobacco Units

    7,502

    6,122

    22.5%

     

    24,890

    22,607

    10.1%

    Total SSEA, CIS & MEA

    90,511

    90,042

    0.5%

     

    358,243

    353,633

    1.3%

    Fourth-Quarter

    The estimated total market for cigarettes and HTUs in the Region decreased by approximately 1% to 389.2 billion units, due to a decline for cigarettes. The decrease in the estimated total market was mainly due to Egypt (down by 21.8%) and Pakistan (down by 25.1%), partly offset by Turkey (up by 13.3%).

    PMI's total cigarette and HTU shipment volume in the Region increased by 0.5% to 90.5 billion units, mainly driven by Turkey (up by 19.0%), partly offset by the Philippines (down by 25.5%). PMI's estimated HTU adjusted in-market sales volume increased by 13.0%, with 22.5% HTU shipment volume growth, primarily due to comparison effects, notably in Russia.

    Full-Year

    The estimated total market for cigarettes and HTUs in the Region decreased by approximately 2% to 1,528.6 billion units, due to a decline for cigarettes. The decrease in the estimated total market was predominantly due to Egypt (down by 20.9%) and Pakistan (down by 35.1%), partly offset by Turkey (up by 16.9%).

    Our Regional market share increased by 0.8 points to 23.4%.

    PMI's total cigarette and HTU shipment volume in the Region increased by 1.3% to 358.2 billion units, mainly driven by Turkey (up by 23.0%), partly offset by the Philippines (down by 26.2%). PMI's estimated HTU adjusted in-market sales volume increased by 8.2% including limited growth in Russia.

    Financial Summary

    Fourth-Quarter

    Financial Summary - Quarters Ended December 31,

     

     

     

     

     

    Change

    Fav./(Unfav.)

     

    Variance

    Fav./(Unfav.)

     

    2023

     

    2022

     

    Total

     

    Excl.

    Curr. &

    Acquis.

     

    Total

     

    Cur-

    rency

     

    Acqui-

    sitions

     

    Price

     

    Vol/

    Mix

     

    Cost/

    Other

    (in millions)

     

     

     

     

     

     

     

     

     

     

    Net Revenues

     

    $

    2,707

     

    $

    2,686

     

     

    0.8

    %

    13.0

    %

     

    21

     

    (327

    )

    —

    257

    97

     

    (6

    )

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Operating Income

     

    $

    676

     

    $

    855

     

     

    (20.9

    )%

    3.0

    %

     

    (179

    )

    (205

    )

    —

    257

    (49

    )

    (182

    )

    Adjustments (1)

     

     

    (5

    )

     

    38

     

     

    -(100

    )%

    -(100

    )%

     

    (43

    )

    —

     

    —

    —

    —

     

    (43

    )

    Adjusted Operating Income

     

    $

    681

     

    $

    817

     

     

    (16.6

    )%

    8.4

    %

     

    (136

    )

    (205

    )

    —

    257

    (49

    )

    (139

    )

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Adjusted Operating Income Margin

     

     

    25.2

    %

     

    30.4

    %

     

    (5.2

    )pp

    (1.2

    )pp

     

     

     

     

     

     

     

    (1) See Schedule 8 in Exhibit 99.2 to the Form 8-K dated February 8, 2024, for additional detail.

    Net revenues increased by 13.0% on an organic basis, primarily reflecting: a favorable pricing variance, mainly driven by higher combustible tobacco pricing; and favorable volume/mix, driven by higher HTU volume and favorable cigarette mix, partly offset by lower cigarette volume.

    Adjusted operating income increased by 8.4% on an organic basis, primarily reflecting: the favorable pricing variance, partly offset by higher marketing, administration and research costs; higher manufacturing costs (primarily due to inflationary impacts); and unfavorable volume/mix, mainly due to an unfavorable cigarette volume impact.

    Full-Year

    Financial Summary - Years Ended December 31,

     

     

     

     

    Change

    Fav./(Unfav.)

     

    Variance

    Fav./(Unfav.)

     

    2023

     

    2022

     

    Total

     

    Excl.

    Curr. &

    Acquis.

     

    Total

     

    Cur-

    rency

     

    Acqui-

    sitions

     

    Price

     

    Vol/

    Mix

     

    Cost/

    Other

    (in millions)

     

     

     

     

     

     

     

     

     

     

    Net Revenues

     

    $

    10,629

     

    $

    10,467

     

     

    1.5

    %

    11.7

    %

     

    162

     

    (1,060

    )

    —

    1,008

    400

     

    (186

    )

    Adjustment (1)

     

     

    (80

    )

     

    —

     

     

    —

    %

    —

    %

     

    (80

    )

    —

     

    —

    —

    —

     

    (80

    )

    Adjusted Net Revenues

     

    $

    10,709

     

    $

    10,467

     

     

    2.3

    %

    12.4

    %

     

    242

     

    (1,060

    )

    —

    1,008

    400

     

    (106

    )

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Net Revenues

     

    $

    10,629

     

    $

    10,467

     

     

    1.5

    %

    11.7

    %

     

    162

     

    (1,060

    )

    —

    1,008

    400

     

    (186

    )

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Operating Income

     

    $

    3,047

     

    $

    3,864

     

     

    (21.1

    )%

    (4.2

    )%

     

    (817

    )

    (653

    )

    —

    1,008

    (237

    )

    (935

    )

    Adjustments (2)

     

     

    (178

    )

     

    (56

    )

     

    -(100

    )%

    -(100

    )%

     

    (122

    )

    —

     

    —

    —

    —

     

    (122

    )

    Adjusted Operating Income

     

    $

    3,225

     

    $

    3,920

     

     

    (17.7

    )%

    (1.1

    )%

     

    (695

    )

    (653

    )

    —

    1,008

    (237

    )

    (813

    )

     

    Adjusted Operating Income Margin

     

     

    30.1

    %

     

    37.5

    %

     

    (7.4

    )pp

    (4.5

    )pp

     

     

     

     

     

     

     

    (1) Termination of distribution arrangement in the Middle East

    (2) See Schedule 9 in Exhibit 99.2 to the Form 8-K dated February 8, 2024, for additional detail.

    Adjusted net revenues increased by 12.4% on an organic basis, primarily reflecting: a favorable pricing variance, mainly driven by higher combustible tobacco pricing, with HTU pricing also higher; favorable volume/mix, primarily driven by favorable cigarette mix, as well as higher volume for HTUs, partly offset by an unfavorable cigarette volume impact; and partially offset by lower fees for certain distribution rights billed to customers in certain markets, shown in "Cost/Other."

    Adjusted operating income decreased by 1.1% on an organic basis, primarily reflecting: higher marketing, administration and research costs; higher manufacturing costs (primarily due to inflationary impacts); unfavorable volume/mix, mainly due to an unfavorable cigarette volume impact and unfavorable cigarette mix, partly offset by higher HTU volume; and the impact of lower fees for certain distribution rights, as noted for net revenues; partially offset by the favorable pricing variance.

    EA, AU AND PMI DF REGION

    Total Market, PMI Shipment & Market Share Commentaries

    PMI Shipment Volume

    Fourth-Quarter

    Full-Year

    (million units)

    2023

    2022

    Change

    2023

    2022

    Change

    Cigarettes

    11,287

    12,335

    (8.5)%

    50,689

    54,251

    (6.6)%

    Heated Tobacco Units

    11,958

    12,785

    (6.5)%

    50,519

    40,613

    24.4%

    Total EA, AU & PMI DF

    23,245

    25,120

    (7.5)%

    101,208

    94,864

    6.7%

    Fourth-Quarter

    The estimated total market for cigarettes and HTUs in the Region, excluding China, decreased by around 1% to 80.7 billion units, with growth for HTUs more than offset by a decline for cigarettes. The decrease in the estimated total market was driven by Taiwan (down by 18.1%), partly offset by International Duty Free (up by 26.3%).

    PMI's total cigarette and HTU shipment volume in the Region decreased by 7.5% to 23.2 billion units, driven by Japan (down by 13.3%).

    PMI's estimated HTU adjusted in-market sales volume in the Region increased by 15.4% in the quarter, including growth in Japan of 13.4%, primarily due to comparison effects.

    Full-Year

    The estimated total market for cigarettes and HTUs in the Region, excluding China, increased by 1% to 319.8 billion units, reflecting growth for HTUs, partly offset by a decline for cigarettes. The increase in the estimated total market was mainly driven by International Duty Free (up by 35.7%), partly offset by Taiwan (down by 7.4%) and Australia (down by 19.4%).

    Our Regional market share increased by 1.3 points to 30.0%.

    PMI's total cigarette and HTU shipment volume in the Region increased by 6.7% to 101.2 billion units, mainly driven by Japan (up by 9.7%) and International Duty Free (up by 14.5%).

    PMI's estimated HTU adjusted in-market sales volume in the Region increased by 15.8%, including growth in Japan of 14.5%.

    Financial Summary

    Fourth-Quarter

    Financial Summary - Quarters Ended December 31,

     

     

     

     

     

    Change

    Fav./(Unfav.)

     

    Variance

    Fav./(Unfav.)

     

    2023

     

    2022

     

    Total

     

    Excl.

    Curr. &

    Acquis.

     

    Total

     

    Cur-

    rency

     

    Acqui-

    sitions

     

    Price

     

    Vol/

    Mix

     

    Cost/

    Other

    (in millions)

     

     

     

     

     

     

     

     

     

     

    Net Revenues

     

    $

    1,430

     

    $

    1,478

     

     

    (3.2

    )%

    (0.1

    )%

     

    (48

    )

    (46

    )

    —

    133

    (135

    )

    —

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Operating Income

     

    $

    561

     

    $

    678

     

     

    (17.3

    )%

    (5.2

    )%

     

    (117

    )

    (82

    )

    —

    133

    (133

    )

    (35

    )

    Adjustments (1)

     

     

    —

     

     

    31

     

     

    -(100

    )%

    -(100

    )%

     

    (31

    )

    —

     

    —

    —

    —

     

    (31

    )

    Adjusted Operating Income

     

    $

    561

     

    $

    647

     

     

    (13.3

    )%

    (0.6

    )%

     

    (86

    )

    (82

    )

    —

    133

    (133

    )

    (4

    )

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Adjusted Operating Income Margin

     

     

    39.2

    %

     

    43.8

    %

     

    (4.6

    )pp

    (0.2

    )pp

     

     

     

     

     

     

     

    (1) See Schedule 8 in Exhibit 99.2 to the Form 8-K dated February 8, 2024, for additional detail.

    Net revenues decreased by 0.1% on an organic basis, reflecting: unfavorable volume/mix, mainly driven by lower cigarette and HTU volume; largely offset by favorable pricing variance, driven by higher combustible tobacco pricing.

    Adjusted operating income decreased by 0.6% on an organic basis driven by the same factors as for net revenues.

    Full-Year

    Financial Summary - Years Ended December 31,

     

     

     

     

     

    Change

    Fav./(Unfav.)

     

    Variance

    Fav./(Unfav.)

     

    2023

     

    2022

     

    Total

     

    Excl.

    Curr. &

    Acquis.

     

    Total

     

    Cur-

    rency

     

    Acqui-

    sitions

     

    Price

     

    Vol/

    Mix

     

    Cost/

    Other

    (in millions)

     

     

     

     

     

     

     

     

     

     

    Net Revenues

     

    $

    6,201

     

    $

    5,936

     

     

    4.5

    %

    11.2

    %

     

    265

     

    (400

    )

    —

    206

    459

    —

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Operating Income

     

    $

    2,481

     

    $

    2,424

     

     

    2.4

    %

    18.6

    %

     

    57

     

    (395

    )

    —

    206

    326

    (80

    )

    Adjustments (1)

     

     

    (254

    )

     

    (28

    )

     

    -(100

    )%

    -(100

    )%

     

    (226

    )

    —

     

    —

    —

    —

    (226

    )

    Adjusted Operating Income

     

    $

    2,735

     

    $

    2,452

     

     

    11.5

    %

    27.7

    %

     

    283

     

    (395

    )

    —

    206

    326

    146

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Adjusted Operating Income Margin

     

     

    44.1

    %

     

    41.3

    %

     

    2.8

    pp

    6.1

    pp

     

     

     

     

     

     

     

    (1) See Schedule 9 in Exhibit 99.2 to the Form 8-K dated February 8, 2024, for additional detail.

    Net revenues increased by 11.2% on an organic basis, reflecting: favorable volume/mix, mainly driven by higher HTU volume, partly offset by lower cigarette volume and unfavorable smoke-free product mix (for HTUs and devices); and a favorable pricing variance, driven by higher combustible tobacco and device pricing, partly offset by lower HTU (net) pricing (primarily related to Japan).

    Adjusted operating income increased by 27.7% on an organic basis, mainly reflecting favorable volume/mix, primarily driven by higher HTU volume, partly offset by lower cigarette volume and unfavorable HTU mix; the favorable pricing variance; and lower supply chain costs (primarily related to Japan).

    AMERICAS REGION

    Total Market, PMI Shipment & Market Share Commentaries

    PMI Shipment Volume

    Fourth-Quarter

    Full-Year

    (million units)

    2023

    2022

    Change

    2023

    2022

    Change

    Cigarettes

    17,468

    18,432

    (5.2)%

    63,314

    65,973

    (4.0)%

    Heated Tobacco Units

    202

    193

    4.7%

    585

    532

    10.0%

    Total Americas

    17,670

    18,625

    (5.1)%

    63,899

    66,505

    (3.9)%

    Fourth-Quarter

    The estimated total market for cigarettes and HTUs in the Region, excluding the U.S., decreased by around 2% to 49.9 billion units, primarily reflecting a decline for cigarettes. The decrease in the estimated total market was mainly due to Mexico (down by 8.7%), Argentina (down by 8.1%) and Canada (down by 11.2%), partly offset by Brazil (up by 11.7%).

    PMI's total cigarette and HTU shipment volume in the Region decreased by 5.1% to 17.7 billion units, mainly due to Mexico (down by 11.6%) and Argentina (down by 10.7%), partly offset by Brazil (up by 13.3%).

    Full-Year

    The estimated total market for cigarettes and HTUs in the Region, excluding the U.S., decreased by around 1% to 189.2 billion units, driven by a decline for cigarettes. The decrease in the estimated total market was mainly due to Mexico (down by 6.8%), Canada (down by 12.6%) and Argentina (down by 5.0%), partly offset by Brazil (up by 10.1%).

    Our Regional market share, excluding the U.S., decreased by 1.1 points to 33.7%.

    PMI's total cigarette and HTU shipment volume in the Region decreased by 3.9% to 63.9 billion units, mainly due to Mexico (down by 9.8%) and Argentina (down by 7.9%), partly offset by Brazil (up by 12.8%).

    Financial Summary

    Fourth-Quarter

    Financial Summary - Quarters Ended December 31,

     

     

     

     

     

    Change

    Fav./(Unfav.)

     

    Variance

    Fav./(Unfav.)

     

    2023

     

    2022

     

    Total

     

    Excl.

    Curr. &

    Acquis.

     

    Total

     

    Cur-

    rency

     

    Acqui-

    sitions

     

    Price

     

    Vol/

    Mix

     

    Cost/

    Other

    (in millions)

     

     

     

     

     

     

     

     

     

     

    Net Revenues

     

    $

    545

     

    $

    536

     

     

    1.7

    %

    (4.9

    )%

     

    9

     

    35

     

    —

    34

    (62

    )

    2

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Operating Income

     

    $

    (79

    )

    $

    100

     

     

    -(100

    )%

    (56.0

    )%

     

    (179

    )

    (123

    )

    —

    34

    (55

    )

    (35

    )

    Adjustments (1)

     

     

    (1

    )

     

    5

     

     

    -(100

    )%

    -(100

    )%

     

    (6

    )

    —

     

    —

    —

    —

     

    (6

    )

    Adjusted Operating Income

     

    $

    (78

    )

    $

    95

     

     

    -(100

    )%

    (52.6

    )%

     

    (173

    )

    (123

    )

    —

    34

    (55

    )

    (29

    )

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Adjusted Operating Income Margin

     

     

    (14.3

    )%

     

    17.7

    %

     

    (32.0

    )pp

    (8.9

    )pp

     

     

     

     

     

     

     

    (1) See Schedule 8 in Exhibit 99.2 to the Form 8-K dated February 8, 2024, for additional detail.

    Net revenues decreased by 4.9% on an organic basis, primarily reflecting: unfavorable volume/mix, mainly due to lower cigarette volume and unfavorable cigarette mix; partly offset by a favorable pricing variance, driven by higher combustible tobacco pricing.

    Adjusted operating income decreased by 52.6% on an organic basis, mainly reflecting: unfavorable volume/mix, mainly due to the same factors as for net revenues; higher marketing and administration costs (including incremental investments in the U.S. in preparation for smoke-free product commercialization); and higher manufacturing costs; partly offset by the favorable pricing variance.

    Full-Year

    Financial Summary - Years Ended December 31,

     

     

     

     

     

    Change

    Fav./(Unfav.)

     

    Variance

    Fav./(Unfav.)

     

    2023

     

    2022

     

    Total

     

    Excl.

    Curr. &

    Acquis.

     

    Total

     

    Cur-

    rency

     

    Acqui-

    sitions

     

    Price

     

    Vol/

    Mix

     

    Cost/

    Other

    (in millions)

     

     

     

     

     

     

     

     

     

     

    Net Revenues

     

    $

    1,944

     

    $

    1,903

     

     

    2.2

    %

    (2.9

    )%

     

    41

     

    96

     

    —

    128

    (177

    )

    (6

    )

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Operating Income

     

    $

    62

     

    $

    436

     

     

    (85.8

    )%

    (40.6

    )%

     

    (374

    )

    (197

    )

    —

    128

    (139

    )

    (166

    )

    Adjustments (1)

     

     

    (19

    )

     

    (14

    )

     

    (35.7

    )%

    (35.7

    )%

     

    (5

    )

    —

     

    —

    —

    —

     

    (5

    )

    Adjusted Operating Income

     

    $

    81

     

    $

    450

     

     

    (82.0

    )%

    (38.2

    )%

     

    (369

    )

    (197

    )

    —

    128

    (139

    )

    (161

    )

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Adjusted Operating Income Margin

     

     

    4.2

    %

     

    23.6

    %

     

    (19.4

    )pp

    (8.6

    )pp

     

     

     

     

     

     

     

    (1) See Schedule 9 in Exhibit 99.2 to the Form 8-K dated February 8, 2024, for additional detail.

    Net revenues decreased by 2.9% on an organic basis, primarily reflecting: unfavorable volume/mix, mainly due to lower cigarette volume and unfavorable cigarette mix; partly offset by a favorable pricing variance, driven by higher combustible tobacco pricing.

    Adjusted operating income decreased by 38.2% on an organic basis, mainly reflecting: higher marketing, administration and research costs (notably reflecting the same factors as in the quarter); unfavorable volume/mix, mainly due to the same factors as for net revenues; partly offset by the favorable pricing variance.

    SWEDISH MATCH

    PMI Shipment Commentary

    Swedish Match Oral Product Shipment Volume (1)

    Fourth-Quarter

    Full-Year

    (million cans)

    2023

    2022

    Change

    2023

    2022

    Change

    Nicotine Pouches

     

     

     

     

     

     

    U.S.

    116.3

    34.5

    +100%

    384.8

    34.5

    +100%

    Scandinavia

    7.1

    3.7

    90.9%

    28.7

    3.7

    +100%

    Other

    1.0

    1.2

    (15.1)%

    4.6

    1.2

    +100%

    Total Nicotine Pouches

    124.4

    39.4

    +100%

    418.2

    39.4

    +100%

     

     

     

     

     

     

     

    Snus

     

     

     

     

     

     

    Scandinavia

    55.5

    39.3

    41.4%

    218.2

    39.3

    +100%

    Other

    1.6

    1.1

    41.4%

    6.8

    1.1

    +100%

    Total Snus

    57.1

    40.4

    41.4%

    224.9

    40.4

    +100%

     

     

     

     

     

     

     

    Moist Snuff

    31.2

    16.0

    95.5%

    133.7

    16.0

    +100%

     

     

     

     

     

     

     

    Other

    0.8

    —

    —%

    4.2

    —

    —%

     

     

     

     

     

     

     

    Total Oral Products

    213.6

    95.8

    +100%

    781.0

    95.8

    +100%

    (1) Excluding U.S. chew

     

     

     

     

     

     

    Volume comparisons versus Swedish Match's 2022 results reflect data sourced from its disclosures, available at www.swedishmatch.com/investors.

    Fourth-Quarter

    Swedish Match's total shipment volume for oral products increased by 21.9% versus its corresponding shipments of 175.2 million cans in the fourth quarter of 2022.

    Nicotine pouch shipment volume increased by 68.6% compared to Swedish Match's fourth-quarter 2022 shipment volume of 73.8 million cans, mainly driven by 78.2% growth for ZYN in the U.S. -- an outstanding performance that reflected continued broad strength across the country. In Scandinavia, shipment volume for nicotine pouches grew by 3.0%.

    Shipment volume for snus declined by 17.6% compared to Swedish Match's fourth-quarter 2022 shipment volume of 69.3 million cans. The decrease was primarily due to Scandinavia, mainly reflecting the comparison versus a strong total market in the prior year period.

    Full-Year

    Swedish Match's total shipment volume for oral products increased by 17.1% versus its corresponding shipments of 667.1 million cans in 2022.

    Nicotine pouch shipment volume increased by 55.3% compared to Swedish Match's 2022 shipment volume of 269.2 million cans, reflecting 62.0% growth for ZYN in the U.S. In Scandinavia, shipment volume for nicotine pouches grew by 6.1%.

    Shipment volume for snus declined by 13.8% compared to Swedish Match's 2022 shipment volume of 261.0 million cans.

    Swedish Match's performance in the period primarily reflected the same factors as in the quarter, coupled with the impact of excise tax and price increases on snus in Scandinavia in the first quarter (including related inventory movements).

    Swedish Match Combustible Product Shipment Volume

    Fourth-Quarter

    Full-Year

    (million units)

    2023

    2022

    Change

    2023

    2022

    Change

    Cigars

    337.1

    259.6

    29.9%

    1,578.6

    259.6

    +100%

    Fourth-Quarter

    Cigar shipment volume declined by 26.4% compared to Swedish Match's fourth-quarter 2022 cigar shipment volume of 458.3 million units, primarily due to the impact of industry pricing effects.

    Full-Year

    Cigar shipment volume declined by 12.2% compared to Swedish Match's 2022 cigar shipment volume of 1,798.0 million units, mainly due to the same factor as in the quarter.

    Fourth-Quarter

    Financial Summary - Quarters Ended December 31,

     

     

     

     

     

    Change

    Fav./(Unfav.)

     

    Variance

    Fav./(Unfav.)

     

    2023

     

    2022 (2)

     

    Total

     

    Excl.

    Curr. &

    Acquis.

     

    Total

     

    Cur-

    rency

     

    Acqui-

    sitions

     

    Price

     

    Vol/

    Mix

     

    Cost/

    Other

    (in millions)

     

     

     

     

     

     

     

     

     

     

    Net Revenues

     

    $

    682

     

    $

    316

     

     

    +100

    %

    21.2

    %

     

    366

    —

     

    299

     

    25

    42

    —

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Operating Income / (Loss)

     

    $

    227

     

    $

    (22

    )

     

    +100

    %

    +100

    %

     

    249

    (8

    )

    97

     

    25

    38

    97

    Adjustments (1)

     

     

    (98

    )

     

    (151

    )

     

    35.1

    %

    62.3

    %

     

    53

    —

     

    (41

    )

    —

    —

    94

    Adjusted Operating Income

     

    $

    325

     

    $

    129

     

     

    +100%

    51.2

    %

     

    196

    (8

    )

    138

     

    25

    38

    3

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Adjusted Operating Income Margin

     

     

    47.7

    %

     

    40.8

    %

     

    6.9

    pp

    10.1

    pp

     

     

     

     

     

     

     

    (1) See Schedule 8 in Exhibit 99.2 to the Form 8-K dated February 8, 2024, for additional detail.

    (2) Swedish Match's results beginning on November 11, 2022, when PMI became the owner of a majority position in the company, through December 31, 2022

    PMI recorded net revenues of $682 million in the Swedish Match segment for the fourth-quarter. Compared to Swedish Match's full fourth-quarter 2022 results, net revenues increased by 25.7%, excluding currency. This was mainly driven by the strong growth of smoke-free products, led by nicotine pouch volume growth in the U.S.

    PMI recorded adjusted operating income of $325 million in the segment, reflecting an adjusted operating income margin of 47.7%.

    Full-Year

    Financial Summary - Years Ended December 31,

     

     

     

     

     

    Change

    Fav./(Unfav.)

     

    Variance

    Fav./(Unfav.)

     

    2023

     

    2022 (2)

     

    Total

     

    Excl.

    Curr. &

    Acquis.

     

    Total

     

    Cur-

    rency

     

    Acqui-

    sitions

     

    Price

     

    Vol/

    Mix

     

    Cost/

    Other

    (in millions)

     

     

     

     

     

     

     

     

     

     

    Net Revenues

     

    $

    2,496

     

    $

    316

     

     

    +100

    %

    21.2

    %

     

    2,180

     

    —

     

    2,113

     

    25

    42

    —

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Operating Income

     

    $

    824

     

    $

    (22

    )

     

    +100

    %

    +100

    %

     

    846

     

    (8

    )

    694

     

    25

    38

    97

    Adjustments (1)

     

     

    (390

    )

     

    (151

    )

     

    -(100

    )%

    62.3

    %

     

    (239

    )

    —

     

    (333

    )

    —

    —

    94

    Adjusted Operating Income

     

    $

    1,214

     

    $

    129

     

     

    +100

    %

    51.2

    %

     

    1,085

     

    (8

    )

    1,027

     

    25

    38

    3

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Adjusted Operating Income Margin

     

     

    48.6

    %

     

    40.8

    %

     

    7.8

    pp

    10.1

    pp

     

     

     

     

     

     

     

    (1) See Schedule 9 in Exhibit 99.2 to the Form 8-K dated February 8, 2024, for additional detail.

    (2) Swedish Match's results beginning on November 11, 2022, when PMI became the owner of a majority position in the company, through December 31, 2022

    PMI recorded net revenues of $2.5 billion in the Swedish Match segment for the full-year period, with smoke-free products accounting for over 80% of the segment's total net revenues. Compared to Swedish Match's full 2022 results for the same period, net revenues increased by 20.1%, excluding currency. This was mainly driven by the strong growth of smoke-free products, led by nicotine pouch volume growth in the U.S., as well as higher pricing for cigars.

    PMI recorded adjusted operating income of $1,214 million in the segment, reflecting an adjusted operating income margin of 48.6%.

    WELLNESS AND HEALTHCARE

    The operating results of PMI's Vectura Fertin Pharma business are reported in the Wellness and Healthcare segment.

    Financial Summary

    Fourth-Quarter

    Financial Summary - Quarters Ended December 31,

     

     

     

     

     

    Change

    Fav./(Unfav.)

     

    Variance

    Fav./(Unfav.)

     

    2023

     

    2022

     

    Total

     

    Excl.

    Curr. &

    Acquis.

     

    Total

     

    Cur-

    rency

     

    Acqui-

    sitions

     

    Price

     

    Vol/

    Mix

     

    Cost/

    Other

    (in millions)

     

     

     

     

     

     

     

     

     

     

    Net Revenues

     

    $

    69

     

    $

    72

     

     

    (4.2

    )%

    (11.1

    )%

     

    (3

    )

    5

     

    —

    (5

    )

    —

    (3

    )

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Operating Income / (Loss)

     

    $

    (62

    )

    $

    (42

    )

     

    (47.6

    )%

    (35.7

    )%

     

    (20

    )

    (5

    )

    —

    (5

    )

    —

    (10

    )

    Adjustments (1)

     

     

    (15

    )

     

    (13

    )

     

    (15.4

    )%

    (15.4

    )%

     

    (2

    )

    —

     

    —

    —

     

    —

    (2

    )

    Adjusted Operating Income / (Loss)

     

    $

    (47

    )

    $

    (29

    )

     

    (62.1

    )%

    (44.8

    )%

     

    (18

    )

    (5

    )

    —

    (5

    )

    —

    (8

    )

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Adjusted Operating Income / (Loss) Margin

     

     

    (68.1

    )%

     

    (40.3

    )%

     

    (27.8

    )pp

    (25.3

    )pp

     

     

     

     

     

     

     

    (1) See Schedule 8 in Exhibit 99.2 to the Form 8-K dated February 8, 2024, for additional detail.

    Net revenues decreased by 11.1% on an organic basis. The adjusted operating loss of $47 million was primarily due to commercial investments and higher administration costs.

    Full-Year

    Financial Summary - Years Ended December 31,

     

     

     

     

     

    Change

    Fav./(Unfav.)

     

    Variance

    Fav./(Unfav.)

     

    2023

     

    2022

     

    Total

     

    Excl.

    Curr. &

    Acquis.

     

    Total

     

    Cur-

    rency

     

    Acqui-

    sitions

     

    Price

     

    Vol/

    Mix

     

    Cost/

    Other

    (in millions)

     

     

     

     

     

     

     

     

     

     

    Net Revenues

     

    $

    306

     

    $

    271

     

     

    12.9

    %

    11.8

    %

     

    35

     

    3

     

    —

    33

    —

    (1

    )

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Operating Income / (Loss)

     

    $

    (870

    )

    $

    (258

    )

     

    -(100

    )%

    -(100

    )%

     

    (612

    )

    (6

    )

    —

    33

    —

    (639

    )

    Adjustments (1)

     

     

    (738

    )

     

    (171

    )

     

    -(100

    )%

    -(100

    )%

     

    (567

    )

    —

     

    —

    —

    —

    (567

    )

    Adjusted Operating Income / (Loss)

     

    $

    (132

    )

    $

    (87

    )

     

    (51.7

    )%

    (44.8

    )%

     

    (45

    )

    (6

    )

    —

    33

    —

    (72

    )

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Adjusted Operating Income / (Loss) Margin

     

     

    (43.1

    )%

     

    (32.1

    )%

     

    (11.0

    )pp

    (9.5

    )pp

     

     

     

     

     

     

     

    (1) See Schedule 9 in Exhibit 99.2 to the Form 8-K dated February 8, 2024, for additional detail.

    Net revenues increased by 11.8% on an organic basis, notably reflecting the higher net revenues for smoking cessation products and select inhalation products.

    The adjusted operating loss of $132 million was primarily due to commercial investments and higher administration costs.

    Philip Morris International: Delivering a Smoke-Free Future

    Philip Morris International (PMI) is a leading international tobacco company, actively delivering a smoke-free future and evolving its portfolio for the long term to include products outside of the tobacco and nicotine sector. The company's current product portfolio primarily consists of cigarettes and smoke-free products. Since 2008, PMI has invested $12.5 billion to develop, scientifically substantiate and commercialize innovative smoke-free products for adults who would otherwise continue to smoke, with the goal of completely ending the sale of cigarettes. This includes the building of world-class scientific assessment capabilities, notably in the areas of pre-clinical systems toxicology, clinical and behavioral research, as well as post-market studies. In 2022, PMI acquired Swedish Match – a leader in oral nicotine delivery – creating a global smoke-free champion led by the companies' IQOS and ZYN brands. The U.S. Food and Drug Administration has authorized versions of PMI's IQOS Platform 1 devices and consumables and Swedish Match's General snus as Modified Risk Tobacco Products. As of December 31, 2023, PMI's smoke-free products were available for sale in 84 markets, and PMI estimates that approximately 20.8 million adults around the world had already switched to IQOS and stopped smoking. Smoke-free products accounted for approximately 37% of PMI's total full-year 2023 net revenues. With a strong foundation and significant expertise in life sciences, PMI announced in February 2021 its ambition to expand into wellness and healthcare areas and, through its Vectura Fertin Pharma business, aims to enhance life through the delivery of seamless health experiences. For more information, please visit www.pmi.com and www.pmiscience.com.

    Forward-Looking and Cautionary Statements

    This press release contains projections of future results and goals and other forward-looking statements, including statements regarding expected financial or operational performance; capital allocation plans; investment strategies; regulatory outcomes; market expectations; and business plans and strategies. Achievement of future results is subject to risks, uncertainties and inaccurate assumptions. In the event that risks or uncertainties materialize, or underlying assumptions prove inaccurate, actual results could vary materially from those contained in such forward-looking statements. Pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, PMI is identifying important factors that, individually or in the aggregate, could cause actual results and outcomes to differ materially from those contained in any forward-looking statements made by PMI.

    PMI's business risks include: excise tax increases and discriminatory tax structures; increasing marketing and regulatory restrictions that could reduce our competitiveness, eliminate our ability to communicate with adult consumers, or ban certain of our products in certain markets or countries; health concerns relating to the use of tobacco and other nicotine-containing products and exposure to environmental tobacco smoke; litigation related to tobacco use and intellectual property; intense competition; the effects of global and individual country economic, regulatory and political developments, natural disasters and conflicts; the impact and consequences of Russia's invasion of Ukraine; changes in adult smoker behavior; the impact of COVID-19 on PMI's business; lost revenues as a result of counterfeiting, contraband and cross-border purchases; governmental investigations; unfavorable currency exchange rates and currency devaluations, and limitations on the ability to repatriate funds; adverse changes in applicable corporate tax laws; adverse changes in the cost, availability, and quality of tobacco and other agricultural products and raw materials, as well as components and materials for our electronic devices; and the integrity of its information systems and effectiveness of its data privacy policies. PMI's future profitability may also be adversely affected should it be unsuccessful in its attempts to produce and commercialize reduced-risk products or if regulation or taxation do not differentiate between such products and cigarettes; if it is unable to successfully introduce new products, promote brand equity, enter new markets or improve its margins through increased prices and productivity gains; if it is unable to expand its brand portfolio internally or through acquisitions and the development of strategic business relationships; if it is unable to attract and retain the best global talent, including women or diverse candidates; or if it is unable to successfully integrate and realize the expected benefits from recent transactions and acquisitions. Future results are also subject to the lower predictability of our reduced-risk product category's performance.

    PMI is further subject to other risks detailed from time to time in its publicly filed documents, including PMI's Annual Report on Form 10-K for the fourth quarter and year ended December 31, 2022, Quarterly Report on Form 10-Q for the third quarter ended September 30, 2023, and the Form 10-K for the fourth quarter and year ended December 31, 2023, which will be filed later today. PMI cautions that the foregoing list of important factors is not a complete discussion of all potential risks and uncertainties. PMI does not undertake to update any forward-looking statement that it may make from time to time, except in the normal course of its public disclosure obligations.

    Non-GAAP Measures, Glossary and Explanatory Notes

    Reconciliations of non-GAAP measures in this release to the most directly comparable U.S. GAAP measures can be found in Exhibit 99.2 to the Form 8-K dated February 8, 2024, and at www.pmi.com/2023Q4earnings. A glossary of key terms, definitions and explanatory notes is available in the aforementioned Exhibit 99.2 and on the same webpage, where additional financial schedules, as well as adjustments and other calculations have also been made available.

    Management reviews net revenues, gross profit, operating income, operating income margin, operating cash flow and earnings per share, or "EPS," on an adjusted basis, which may exclude the impact of currency and other items such as acquisitions, asset impairment and exit costs, tax items and other special items. Additionally, starting in 2022 and on a comparative basis, for these measures other than net revenues and operating cash flow, PMI includes adjustments to add back amortization expense on acquisition related intangible assets that are recorded as part of purchase accounting and contribute to PMI's revenue generation, as well as impairment of intangible assets, if any. While amortization expense on acquisition related intangible assets is excluded in these adjusted measures, the net revenues generated from these acquired intangible assets are included in the company's adjusted measures, unless otherwise stated. Currency-neutral and organic growth rates reflect the way management views underlying performance for these measures. PMI believes that such measures provide useful insight into underlying business trends and results. Management reviews these measures because they exclude changes in currency exchange rates and other factors that may distort underlying business trends, thereby improving the comparability of PMI's business performance between reporting periods. Furthermore, PMI uses several of these measures in its management compensation program to promote internal fairness and a disciplined assessment of performance against company targets. PMI discloses these measures to enable investors to view the business through the eyes of management.

    Non-GAAP measures used in this release should neither be considered in isolation nor as a substitute for the financial measures prepared in accordance with U.S. GAAP.

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Appendix 1

    PHILIP MORRIS INTERNATIONAL INC. and Subsidiaries

    Key Market Data

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Quarters Ended December 31,

    Market

     

    Total Market,

    bio units

     

    PMI Shipments, bio units

     

    PMI Market Share, % (2)

     

     

    Total

     

    Cigarette

     

    HTU

     

    Total

     

    HTU

     

    2023

    2022

    %

    Change

     

    2023

    2022

    %

    Change

     

    2023

    2022

    %

    Change

     

    2023

    2022

    %

    Change

     

    2023

    2022

    pp

    Change

     

    2023

    2022

    pp

    Change

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Total (1) (2)

     

    650.5

    658.7

    (1.2)

     

    185.1

    186.0

    (0.5)

     

    151.1

    154.0

    (1.9)

     

    34.0

    32.0

    6.1

     

    28.6

    28.1

    0.5

     

    4.9

    4.3

    0.6

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Europe

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    France

     

    7.1

    7.7

    (7.3)

     

    2.8

    3.2

    (13.7)

     

    2.7

    3.1

    (13.1)

     

    —

    0.1

    (40.7)

     

    43.1

    43.6

    (0.5)

     

    0.7

    0.8

    (0.1)

    Germany (3)

     

    16.0

    16.0

    (0.2)

     

    6.6

    7.1

    (6.2)

     

    5.7

    5.8

    (2.2)

     

    1.0

    1.3

    (24.3)

     

    38.9

    39.7

    (0.8)

     

    5.6

    4.7

    0.9

    Italy

     

    18.2

    17.8

    2.5

     

    10.6

    10.2

    4.0

     

    6.5

    6.4

    2.0

     

    4.1

    3.8

    7.5

     

    54.7

    54.3

    0.4

     

    19.0

    15.4

    3.6

    Poland

     

    13.1

    12.8

    2.3

     

    5.6

    5.1

    10.6

     

    4.3

    4.1

    6.5

     

    1.3

    1.0

    27.8

     

    42.8

    39.6

    3.2

     

    9.6

    7.7

    1.9

    Spain

     

    10.6

    10.6

    (0.7)

     

    2.9

    3.0

    (2.5)

     

    2.6

    2.8

    (6.4)

     

    0.3

    0.2

    53.2

     

    28.8

    28.9

    (0.1)

     

    2.4

    1.9

    0.5

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    SSEA, CIS & MEA

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Egypt

     

    19.3

    24.6

    (21.8)

     

    6.2

    5.9

    5.2

     

    5.6

    5.4

    3.8

     

    0.6

    0.5

    21.7

     

    31.4

    22.2

    9.2

     

    2.0

    0.9

    1.1

    Indonesia

     

    72.5

    73.4

    (1.2)

     

    20.3

    21.2

    (4.1)

     

    20.3

    21.2

    (4.1)

     

    —

    —

    —

     

    28.0

    28.9

    (0.9)

     

    —

    —

    —

    Philippines

     

    10.7

    13.0

    (17.7)

     

    5.8

    7.7

    (25.5)

     

    5.7

    7.6

    (25.6)

     

    0.1

    0.1

    (15.0)

     

    53.7

    59.4

    (5.7)

     

    0.6

    0.6

    —

    Russia

     

    52.4

    52.1

    0.6

     

    16.5

    16.1

    2.4

     

    11.4

    12.0

    (4.7)

     

    5.1

    4.1

    23.3

     

    31.3

    31.8

    (0.5)

     

    8.3

    7.8

    0.5

    Turkey

     

    35.3

    31.1

    13.3

     

    18.7

    15.7

    19.0

     

    18.7

    15.7

    19.0

     

    —

    —

    —

     

    52.9

    50.4

    2.5

     

    —

    —

    —

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    EA, AU & PMI DF

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Australia

     

    1.6

    2.3

    (32.4)

     

    0.5

    0.8

    (32.9)

     

    0.5

    0.8

    (32.9)

     

    —

    —

    —

     

    32.7

    32.9

    (0.2)

     

    —

    —

    —

    Japan (2)

     

    37.8

    37.8

    —

     

    13.9

    16.1

    (13.3)

     

    3.9

    5.0

    (21.2)

     

    10.0

    11.1

    (9.7)

     

    40.0

    38.0

    2.0

     

    27.6

    24.4

    3.2

    South Korea

     

    17.8

    17.6

    1.1

     

    3.4

    3.3

    2.9

     

    2.1

    2.1

    (2.3)

     

    1.3

    1.2

    12.2

     

    19.3

    19.1

    0.2

     

    7.5

    6.7

    0.8

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Americas

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Argentina

     

    7.1

    7.8

    (8.1)

     

    4.4

    4.9

    (10.7)

     

    4.4

    4.9

    (10.7)

     

    —

    —

    —

     

    61.7

    63.5

    (1.8)

     

    —

    —

    —

    Mexico

     

    8.8

    9.6

    (8.7)

     

    5.7

    6.5

    (11.6)

     

    5.7

    6.4

    (11.5)

     

    —

    —

    —

     

    65.3

    67.4

    (2.1)

     

    0.5

    0.5

    —

    (1) Market share estimates are calculated using IMS data, unless otherwise stated

    (2) Total market and market share estimates include cigarillos in Japan

    (3) PMI market share reflects estimated adjusted in-market sales volume share. Historical HTU adjusted in-market sales volume share: Q1, 2023 (5.4%); Q2, 2023 (5.4%); Q3 2023 (4.9%). Historical total adjusted in-market sales volume share: Q1, 2023 (39.4%); Q2, 2023 (39.2%); Q3, 2023 (38.4%);

    Note: % change for Total Market and PMI shipments is computed based on millions of units. "-" indicates volume below 50 million units and market share below 0.1%

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Appendix 2

    PHILIP MORRIS INTERNATIONAL INC. and Subsidiaries

    Key Market Data

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Years Ended December 31,

    Market

     

    Total Market,

    bio units

     

    PMI Shipments, bio units

     

    PMI Market Share, %(2)

     

     

    Total

     

    Cigarette

     

    HTU

     

    Total

     

    HTU

     

    2023

    2022

    %

    Change

     

    2023

    2022

    %

    Change

     

    2023

    2022

    %

    Change

     

    2023

    2022

    %

    Change

     

    2023

    2022

    pp

    Change

     

    2023

    2022

    pp

    Change

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Total (1) (2)

     

    2,579.9

    2,621.5

    (1.6)

     

    738.2

    731.1

    1.0

     

    612.9

    621.9

    (1.4)

     

    125.3

    109.2

    14.7

     

    28.3

    27.7

    0.6

     

    4.7

    4.1

    0.6

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Europe

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    France

     

    29.8

    32.5

    (8.2)

     

    13.0

    14.0

    (7.3)

     

    12.8

    13.7

    (7.2)

     

    0.2

    0.2

    (13.1)

     

    42.5

    43.6

    (1.1)

     

    0.7

    0.7

    —

    Germany (3)

     

    69.0

    70.3

    (1.8)

     

    26.5

    28.2

    (6.0)

     

    23.3

    24.8

    (5.7)

     

    3.1

    3.4

    (8.3)

     

    39.0

    38.9

    0.1

     

    5.3

    4.0

    1.3

    Italy

     

    73.3

    72.8

    0.7

     

    39.7

    40.8

    (2.8)

     

    27.3

    28.6

    (4.5)

     

    12.4

    12.3

    1.1

     

    53.9

    54.1

    (0.2)

     

    17.3

    14.6

    2.7

    Poland

     

    56.7

    55.7

    1.8

     

    23.7

    21.7

    9.4

     

    18.7

    17.1

    9.0

     

    5.0

    4.5

    10.8

     

    41.8

    38.9

    2.9

     

    8.9

    8.2

    0.7

    Spain

     

    43.6

    44.6

    (2.4)

     

    12.9

    13.6

    (5.5)

     

    11.8

    12.7

    (7.4)

     

    1.1

    0.9

    22.6

     

    29.3

    30.0

    (0.7)

     

    2.3

    1.7

    0.6

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    SSEA, CIS & MEA

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Egypt

     

    74.0

    93.6

    (20.9)

     

    24.3

    21.0

    15.4

     

    23.0

    20.0

    14.8

     

    1.3

    1.0

    26.9

     

    32.8

    22.2

    10.6

     

    1.7

    0.8

    0.9

    Indonesia

     

    291.6

    304.0

    (4.1)

     

    83.4

    86.8

    (4.0)

     

    83.4

    86.8

    (4.0)

     

    —

    —

    —

     

    28.6

    28.6

    —

     

    —

    —

    —

    Philippines

     

    42.9

    53.4

    (19.7)

     

    23.8

    32.2

    (26.2)

     

    23.5

    32.0

    (26.4)

     

    0.2

    0.2

    (0.9)

     

    55.4

    60.3

    (4.9)

     

    0.5

    0.4

    0.1

    Russia

     

    203.4

    208.8

    (2.6)

     

    64.8

    64.7

    0.1

     

    47.9

    49.3

    (2.9)

     

    16.9

    15.4

    9.8

     

    31.8

    31.2

    0.6

     

    8.0

    7.6

    0.4

    Turkey

     

    136.5

    116.8

    16.9

     

    69.0

    56.1

    23.0

     

    69.0

    56.1

    23.0

     

    —

    —

    —

     

    50.5

    48.0

    2.5

     

    —

    —

    —

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    EA, AU & PMI DF

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Australia

     

    7.2

    8.9

    (19.4)

     

    2.5

    3.0

    (16.0)

     

    2.5

    3.0

    (16.0)

     

    —

    —

    —

     

    34.8

    33.4

    1.4

     

    —

    —

    —

    Japan (2)

     

    149.0

    148.3

    0.5

     

    60.9

    55.5

    9.7

     

    17.9

    21.1

    (15.4)

     

    43.0

    34.4

    25.1

     

    39.6

    37.6

    2.0

     

    26.7

    23.6

    3.1

    South Korea

     

    72.0

    72.6

    (0.7)

     

    14.0

    13.9

    0.9

     

    8.9

    9.4

    (5.0)

     

    5.1

    4.5

    13.1

     

    19.5

    19.2

    0.3

     

    7.1

    6.2

    0.9

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Americas

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Argentina

     

    28.8

    30.3

    (5.0)

     

    17.8

    19.3

    (7.9)

     

    17.8

    19.3

    (7.9)

     

    —

    —

    —

     

    61.9

    63.8

    (1.9)

     

    —

    —

    —

    Mexico

     

    30.0

    32.2

    (6.8)

     

    18.9

    21.0

    (9.8)

     

    18.8

    20.8

    (9.9)

     

    0.1

    0.1

    2.4

     

    63.1

    65.2

    (2.1)

     

    0.5

    0.4

    0.1

    (1) Market share estimates are calculated using IMS data, unless otherwise stated

    (2) Total market and market share estimates include cigarillos in Japan

    (3) PMI market share reflects estimated adjusted in-market sales volume share

    Note: % change for Total Market and PMI shipments is computed based on millions of units. "-" indicates volume below 50 million units and market share below 0.1%

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20240207811391/en/

    Get the next $PM alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $PM

    DatePrice TargetRatingAnalyst
    1/20/2026$180.00Buy → Hold
    Jefferies
    7/9/2025$220.00Buy
    Jefferies
    5/22/2025$195.00Buy
    Needham
    4/25/2025$170.00Sell → Neutral
    UBS
    3/14/2025Hold → Buy
    Argus
    1/16/2025$140.00Overweight
    Morgan Stanley
    3/5/2024Buy → Hold
    Argus
    2/13/2024Sell → Hold
    Societe Generale
    More analyst ratings

    $PM
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Philip Morris International Presents its Value Report 2025: change in motion

    The company's annual disclosure unveils its Value Plan 2030+ Philip Morris International (NYSE:PM) today released its Value Report 2025, offering a holistic perspective on the company's approach to sustainable value creation. The report marks the completion of PMI's 2025 Roadmap, communicating achievements for each aspiration introduced by the company in 2020, and introduces its Value Plan 2030+, set to guide the company's continued path to sustainable growth. "For more than a decade, PMI has pursued an industry-leading shift away from cigarettes—a transformation that goes far beyond product innovation to encompass how we allocate capital, engage stakeholders, and measure success," said

    3/31/26 4:30:00 AM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care

    PMI U.S. BRINGS TECHNOVATION TO WASHINGTON D.C.

    PMI's global science and innovation platform brings together leaders to accelerate progress toward a smoke-free futureWASHINGTON, March 30, 2026 /PRNewswire/ -- Technovation, the global science and innovation platform of Philip Morris International (PMI) (NYSE:PM), will make its U.S. debut on April 14. The one-day event brings together experts, policymakers, scientists, media, and business leaders across the Americas to explore how innovation, science, and regulation can accelerate progress toward a smoke-free future. The U.S. launch of Technovation marks a key moment for the pl

    3/30/26 8:00:00 AM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care

    Philip Morris International Declares Regular Quarterly Dividend of $1.47 Per Share

    Regulatory News: The Board of Directors of Philip Morris International Inc. (NYSE:PM) today declared a regular quarterly dividend of $1.47 per common share, payable on April 13, 2026, to shareholders of record as of March 19, 2026. The ex-dividend date is March 19, 2026. For more details on stock, dividends and other information, see www.pmi.com/dividend. Philip Morris International: A Global Smoke-Free Champion Philip Morris International is a leading international consumer goods company, actively delivering a smoke-free future and evolving its portfolio for the long term to include products outside of the tobacco and nicotine sector. The company's current product portfolio primarily

    3/5/26 7:00:00 AM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care

    $PM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Philip Morris International downgraded by Jefferies with a new price target

    Jefferies downgraded Philip Morris International from Buy to Hold and set a new price target of $180.00

    1/20/26 9:10:49 AM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care

    Jefferies resumed coverage on Philip Morris International with a new price target

    Jefferies resumed coverage of Philip Morris International with a rating of Buy and set a new price target of $220.00

    7/9/25 8:31:10 AM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care

    Needham initiated coverage on Philip Morris International with a new price target

    Needham initiated coverage of Philip Morris International with a rating of Buy and set a new price target of $195.00

    5/22/25 8:27:06 AM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care

    $PM
    SEC Filings

    View All

    SEC Form DEFA14A filed by Philip Morris International Inc

    DEFA14A - Philip Morris International Inc. (0001413329) (Filer)

    3/31/26 2:03:06 PM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Philip Morris International Inc

    SCHEDULE 13G/A - Philip Morris International Inc. (0001413329) (Subject)

    3/27/26 11:22:44 AM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form DEFA14A filed by Philip Morris International Inc

    DEFA14A - Philip Morris International Inc. (0001413329) (Filer)

    3/26/26 6:06:32 AM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care

    $PM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Group Controller Dobrowolski Reginaldo covered exercise/tax liability with 22 shares (SEC Form 4)

    4 - Philip Morris International Inc. (0001413329) (Issuer)

    3/9/26 4:23:03 PM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care

    Group Chief Financial Officer Babeau Emmanuel covered exercise/tax liability with 2,228 shares and sold $6,138,418 worth of shares (33,800 units at $181.61), decreasing direct ownership by 18% to 164,463 units (SEC Form 4)

    4 - Philip Morris International Inc. (0001413329) (Issuer)

    2/20/26 4:01:45 PM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care

    Group Controller Dobrowolski Reginaldo covered exercise/tax liability with 250 shares and sold $1,100,880 worth of shares (6,000 units at $183.48), decreasing direct ownership by 20% to 21,182 units (SEC Form 4)

    4 - Philip Morris International Inc. (0001413329) (Issuer)

    2/20/26 4:01:38 PM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care

    $PM
    Leadership Updates

    Live Leadership Updates

    View All

    Philip Morris International Opens Dialogue on the Future of Human Cognition as a Defining Frontier in the Age of AI

    The paper calls for global debate to ensure AI enhances—rather than diminishes—uniquely human strengths in an increasingly automated world Philip Morris International Inc. (NYSE:PM) today released a new white paper, "Human Cognition: The Next Frontier?", inviting leaders across business, policy, and academia to join a global conversation on the evolving role of human cognition as artificial intelligence transforms work, society, and the economy. The white paper explores how human capabilities such as - critical thinking, creativity and adaptability - are poised to become the "superskill" of the future, driving progress in an era of human-machine collaboration. As AI automates routine ta

    1/20/26 5:03:00 AM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care

    Molex, a Parent to Phillips Medisize, Announces Agreement to Acquire the Vectura Group Limited, Expanding Its Drug Delivery Capabilities in Inhalation

    Pharmaceutical customers and patients to benefit from the combined design, development and manufacturing services of Vectura and Phillips Medisize Phillips Medisize to add a market-leading position in inhalation combination product development to its existing suite of drug delivery device design capabilities Vectura employees to join a large global company, dedicated to improving patients' lives through innovative products and world class quality and manufacturing capabilities Molex, a parent to Phillips Medisize, a leader in the design, engineering and manufacturing of pharmaceutical drug delivery, in vitro diagnostic and medtech devices, announced that, through its affiliate Molex

    9/17/24 9:11:00 AM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care

    Philip Morris International Names New External Affairs Leader

    Philip Morris International Inc. (PMI) (NYSE:PM) is pleased to announce the appointment of Christos Harpantidis to the position of Senior Vice President, External Affairs effective May 1, 2024. In his new role, Mr. Harpantidis will report to the company's CEO, Jacek Olczak. "Christos is an experienced business leader with a proven track record of engaging society on the benefits of tobacco harm reduction and risk-proportionate regulation for smoke-free products," said CEO Jacek Olczak. "He has been instrumental in building our smoke-free business in Greece and the South East Europe Area as we evolve away from cigarettes. I'm looking forward to working with Christos and excited to see what

    3/26/24 5:48:00 AM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care

    $PM
    Financials

    Live finance-specific insights

    View All

    Philip Morris International Declares Regular Quarterly Dividend of $1.47 Per Share

    Regulatory News: The Board of Directors of Philip Morris International Inc. (NYSE:PM) today declared a regular quarterly dividend of $1.47 per common share, payable on April 13, 2026, to shareholders of record as of March 19, 2026. The ex-dividend date is March 19, 2026. For more details on stock, dividends and other information, see www.pmi.com/dividend. Philip Morris International: A Global Smoke-Free Champion Philip Morris International is a leading international consumer goods company, actively delivering a smoke-free future and evolving its portfolio for the long term to include products outside of the tobacco and nicotine sector. The company's current product portfolio primarily

    3/5/26 7:00:00 AM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care

    Philip Morris International Presents at 2026 CAGNY Conference; Reaffirms 2026 Full-Year Forecast

    Regulatory News: Philip Morris International Inc.'s (PMI) (NYSE:PM) Group CEO PMI, Jacek Olczak, and Group Chief Financial Officer, Emmanuel Babeau, will address investors today at the 2026 Consumer Analyst Group of New York (CAGNY) Conference at approximately 10:00 a.m. ET. The live webcast and presentation slides will be available here. The webcast replay will be available at the same link for six months after the event. The webcast may also be accessed on mobile devices by downloading PMI's Investor Relations App at www.pmi.com/irapp. The presentation will cover: How a transformed PMI is leading the industry in an evolving operating environment; The success and future opportu

    2/18/26 7:00:00 AM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care

    Philip Morris International Reports 2025 Fourth-Quarter & Full-Year Results

    Delivers Full Year 2025 Reported Diluted EPS of $7.26 compared to $4.52 in 2024 and Adjusted Diluted EPS of $7.54, Representing Growth of 14.8%, and 14.2% on a Currency-Neutral Basis; Provides 2026 - 2028 Growth Targets Regulatory News: Philip Morris International Inc. (PMI) (NYSE:PM) today announces its 2025 fourth quarter results.1 "We achieved another remarkable year of results in 2025, with a fifth consecutive year of volume growth, net revenues surpassing $40 billion, including close to $17 billion from our smoke-free business, and very good operating margin expansion," said Jacek Olczak, Group CEO PMI. "With excellent results in 2024 and 2025, we have delivered our three-year CA

    2/6/26 6:59:00 AM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care

    $PM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Philip Morris International Inc (Amendment)

    SC 13G/A - Philip Morris International Inc. (0001413329) (Subject)

    2/9/24 6:21:26 PM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form SC 13G/A filed by Philip Morris International Inc (Amendment)

    SC 13G/A - Philip Morris International Inc. (0001413329) (Subject)

    2/9/24 6:05:54 PM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form SC 13G/A filed by Philip Morris International Inc (Amendment)

    SC 13G/A - Philip Morris International Inc. (0001413329) (Subject)

    1/29/24 3:26:29 PM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care